Global Precision Medicine Market (2021 to 2028) - Demand for Preventive Care Presents Opportunities

Dublin, IRELAND


Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The publisher predicts that the global market for precision medicine would observe a CAGR of 9.79% over the considered period 2021-2028.

The high prevalence of chronic diseases among the aging population is majorly driving the growth of the studied market. Furthermore, investments by government and private players in the field of cancer and demand for preventive care are generating lucrative opportunities for the precision medicine market. Here, the advancements in technologies have increased awareness regarding personal health, which has led to the rise in demand for preventive care among people.

However, certain factors, such as the stringent drug approval process, along with security threats associated with data sharing, are hindering the overall progress of the precision medicine market.

REGIONAL OUTLOOK

The global precision medicine market encompasses the regions of North America, the Asia-Pacific, Latin America, Europe, and the Middle East and Africa.

The Asia-Pacific is anticipated to showcase the fastest growth rate in the global market over the estimated period. The region's robust growth is primarily due to the surge in healthcare awareness coupled with advanced diagnosis methods. Additionally, numerous advanced human genome libraries produce ethnicity-specific sequences helping scientists to use genetic information to enhance precision medicine research.

Furthermore, the growing need for sequencing technologies due to the rise in the prevalence of diseases has increased the demand for genome mapping programs. Such developments are expected to support the precision medicine market's future growth in the APAC region.

COMPETITIVE OUTLOOK

The enterprises engaged in the precision medicine market are F Hoffmann-La Roche AG, Eagle Genomics Ltd, Eli Lilly & Company, Pfizer Inc, Intomics, Bio-Rad Laboratories Inc, Nanostring Technologies, Novartis AG, Laboratory Corporation of America Holdings, Biocrates Life Sciences AG, Quest Diagnostics Incorporated, Abbott Laboratories, AstraZeneca Plc, Qiagen NV, and Danaher Corporation.

Abbott Laboratories is a pharmaceutical company engaged in manufacturing and marketing a wide range of healthcare products. It provides diagnostic systems, neuromodulation devices, pediatric, and nutritional products. Additionally, it gives products under numerous brand names, including HeartMate, Heptral, and Oxepa. Founded in 1944, Abbott has a global presence across various countries. It is headquartered in the United States.

Key Topics Covered:

1. Global Precision Medicine Market - Summary

2. Industry Outlook
2.1. Key Insights
2.1.1. Presence of Biopharmaceutical Companies
2.1.2. Investments in Gene Therapy
2.2. Impact of COVID-19 on Precision Medicine Market
2.3. Supply Chain Outlook
2.4. Regulatory Policies & Framework
2.5. Etymology of Precision Medicine
2.6. Porter's Five Forces Model
2.7. Market Attractiveness Index
2.8. Vendor Landscape
2.9. Key Market Strategies
2.9.1. Contracts and Partnerships
2.9.2. Business Expansion & Divestitures
2.9.3. Acquisitions & Mergers
2.9.4. New Product Launches
2.10. Market Drivers
2.10.1. High Prevalence of Chronic Diseases in the Aging Population
2.10.2. Digital Collaboration Among Research Groups and Organizations
2.10.3. Identification of Genetic Makeup in the Human Genome
2.11. Market Challenges
2.11.1. Stringent Drug Approval Process
2.11.2. Security Threats Pertaining to Data Sharing
2.11.3. Changes in Reimbursement and Regulatory Process
2.12. Market Opportunities
2.12.1. Investments by Government and Private Players in Cancer Treatment
2.12.2. Demand for Preventive Care

3. Global Precision Medicine Market - by Application
3.1. Oncology
3.2. Infectious Diseases
3.3. Neurology/Physiatry
3.4. Cardiovascular
3.5. Lifestyle and Endocrinology
3.6. Gastroenterology
3.7. Other Applications

4. Global Precision Medicine Market - by Component
4.1. Applied Science
4.1.1. Genomics
4.1.1.1. Pcr
4.1.1.2. Pm Ngs
4.1.1.3. Genome Editing
4.1.1.4. Other Genomics Technologies
4.1.2. Pharmacogenomics
4.1.3. Other Applied Sciences
4.2. Precision Therapeutics
4.2.1. Clinical Trials
4.2.2. Cell Therapy
4.2.3. Drug Discovery and Research
4.2.4. Gene Therapy
4.3. Precision Diagnostics
4.3.1. Molecular Diagnostics
4.3.1.1. Non-Invasive Prenatal Testing (Nipt)
4.3.1.2. Companion Diagnostics
4.3.1.3. Liquid Biopsy
4.3.1.4. Other Molecular Diagnostics
4.3.2. Medical Imaging
4.3.2.1. Imaging Analytics
4.3.2.2. Imaging Computer-Aided Detection (Cadx)
4.4. Digital Health and Information Technology
4.4.1. Clinical Decision Support Systems (Cdss)
4.4.2. Big Data Analytics
4.4.3. It Infrastructure
4.4.4. Genomics Informatics
4.4.5. In-Silico Informatics
4.4.6. Mobile Health

5. Global Precision Medicine Market - Regional Outlook
5.1. North America
5.1.1. Market by Application
5.1.2. Market by Component
5.1.2.1. Applied Science Market by Type
5.1.2.1.1. Genomics Market by Type
5.1.2.2. Precision Therapeutics Market by Type
5.1.2.3. Precision Diagnostics Market by Type
5.1.2.3.1. Molecular Diagnostics Market by Type
5.1.2.3.2. Medical Imaging Market by Type
5.1.2.4. Digital Health and Information Technology Market by Type
5.1.3. Country Analysis
5.1.3.1. United States
5.1.3.2. Canada
5.2. Europe
5.2.1. Market by Application
5.2.2. Market by Component
5.2.2.1. Applied Science Market by Type
5.2.2.1.1. Genomics Market by Type
5.2.2.2. Precision Therapeutics Market by Type
5.2.2.3. Precision Diagnostics Market by Type
5.2.2.3.1. Molecular Diagnostics Market by Type
5.2.2.3.2. Medical Imaging Market by Type
5.2.2.4. Digital Health and Information Technology Market by Type
5.2.3. Country Analysis
5.2.3.1. Germany
5.2.3.2. France
5.2.3.3. United Kingdom
5.2.3.4. Italy
5.2.3.5. Russia
5.2.3.6. Spain
5.2.3.7. Rest of Europe
5.3. Asia-Pacific
5.3.1. Market by Application
5.3.2. Market by Component
5.3.2.1. Applied Science Market by Type
5.3.2.1.1. Genomics Market by Type
5.3.2.2. Precision Therapeutics Market by Type
5.3.2.3. Precision Diagnostics Market by Type
5.3.2.3.1. Molecular Diagnostics Market by Type
5.3.2.3.2. Medical Imaging Market by Type
5.3.2.4. Digital Health and Information Technology Market by Type
5.3.3. Country Analysis
5.3.3.1. China
5.3.3.2. Japan
5.3.3.3. Australia & New Zealand
5.3.3.4. India
5.3.3.5. South Korea
5.3.3.6. Asean Countries
5.3.3.7. Rest of Asia-Pacific
5.4. Latin America
5.4.1. Market by Application
5.4.2. Market by Component
5.4.2.1. Applied Science Market by Type
5.4.2.1.1. Genomics Market by Type
5.4.2.2. Precision Therapeutics Market by Type
5.4.2.3. Precision Diagnostics Market by Type
5.4.2.3.1. Molecular Diagnostics Market by Type
5.4.2.3.2. Medical Imaging Market by Type
5.4.2.4. Digital Health and Information Technology Market by Type
5.4.3. Country Analysis
5.4.3.1. Mexico
5.4.3.2. Brazil
5.4.3.3. Rest of Latin America
5.5. Middle East and Africa
5.5.1. Market by Application
5.5.2. Market by Component
5.5.2.1. Applied Science Market by Type
5.5.2.1.1. Genomics Market by Type
5.5.2.2. Precision Therapeutics Market by Type
5.5.2.3. Precision Diagnostics Market by Type
5.5.2.3.1. Molecular Diagnostics Market by Type
5.5.2.3.2. Medical Imaging Market by Type
5.5.2.4. Digital Health and Information Technology Market by Type
5.5.3. Country Analysis
5.5.3.1. Saudi Arabia
5.5.3.2. United Arab Emirates
5.5.3.3. Turkey
5.5.3.4. South Africa
5.5.3.5. Rest of Middle East & Africa

6. Competitive Landscape
6.1. Abbott Laboratories
6.2. Astrazeneca plc
6.3. Biocrates Life Sciences AG
6.4. Bio-Rad Laboratories Inc
6.5. Danaher Corporation
6.6. Eagle Genomics Ltd
6.7. Eli Lilly & Company
6.8. F Hoffmann-La Roche AG
6.9. Intomics
6.10. Laboratory Corporation of America Holdings
6.11. Nanostring Technologies
6.12. Novartis AG
6.13. Pfizer Inc
6.14. Qiagen Nv
6.15. Quest Diagnostics Incorporated

7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.1.1. Objectives of Study
7.1.2. Scope of Study
7.2. Sources of Data
7.2.1. Primary Data Sources
7.2.2. Secondary Data Sources
7.3. Research Methodology
7.3.1. Evaluation of Proposed Market
7.3.2. Identification of Data Sources
7.3.3. Assessment of Market Determinants
7.3.4. Data Collection
7.3.5. Data Validation & Analysis

For more information about this report visit https://www.researchandmarkets.com/r/6s1vku

 

Contact Data